Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A Cash Flow Quality Index
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A cash flow quality index. Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (600613) has a Cash Flow Quality Index of 6.28x as of September 2025. Operating cash flow of CN¥109.83 Million exceeds net income of CN¥17.49 Million, indicating high earnings quality where cash backs reported profits. See Shanghai Shenqi Pharmaceutical Investmen financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (1998–2025)
Cash flow quality index of Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A from 1998 to 2025. Historical Cash Flow Quality Index for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A across 23 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore 600613 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A Cash Flow Quality Index by Year (1998–2025)
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A cash flow quality index by year from 1998 to 2025. Year-by-year earnings quality comparison for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A. For the full cash flow conversion analysis, see Shanghai Shenqi Pharmaceutical Investmen cash flow conversion.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 3.25x | CN¥124.47 Million | CN¥38.24 Million | ▲ +3.5% |
| 2024 | 3.14x | CN¥207.79 Million | CN¥66.08 Million | ▼ -16.9% |
| 2023 | 3.78x | CN¥215.59 Million | CN¥57.00 Million | ▼ -43.1% |
| 2022 | 6.65x | CN¥319.23 Million | CN¥48.01 Million | ▲ +145.3% |
| 2021 | 2.71x | CN¥184.26 Million | CN¥67.96 Million | ▲ +70.3% |
| 2019 | 1.59x | CN¥128.28 Million | CN¥80.57 Million | ▲ +5.5% |
| 2018 | 1.51x | CN¥148.53 Million | CN¥98.44 Million | ▲ +169.5% |
| 2017 | 0.56x | CN¥66.99 Million | CN¥119.64 Million | ▲ +17240.5% |
| 2016 | 0.00x | CN¥570.41K | CN¥176.65 Million | ▼ -97.7% |
| 2015 | 0.14x | CN¥30.12 Million | CN¥218.27 Million | ▲ +389.6% |
| 2014 | -0.05x | CN¥-8.62 Million | CN¥180.90 Million | ▼ -107.2% |
| 2013 | 0.66x | CN¥74.75 Million | CN¥113.13 Million | ▲ +189.3% |
| 2012 | -0.74x | CN¥-11.18 Million | CN¥15.10 Million | ▼ -326.1% |
| 2011 | -0.17x | CN¥-3.33 Million | CN¥19.16 Million | ▼ -103.3% |
| 2010 | 5.30x | CN¥33.04 Million | CN¥6.24 Million | ▲ +2.5% |
| 2008 | 5.17x | CN¥25.26 Million | CN¥4.89 Million | ▲ +366.2% |
| 2007 | 1.11x | CN¥16.01 Million | CN¥14.44 Million | ▲ +165.5% |
| 2006 | -1.69x | CN¥-6.05 Million | CN¥3.57 Million | ▼ -145.1% |
| 2005 | 3.76x | CN¥32.72 Million | CN¥8.71 Million | ▲ +1131.1% |
| 2004 | 0.31x | CN¥4.96 Million | CN¥16.26 Million | ▼ -82.3% |
| 2000 | 1.73x | CN¥26.85 Million | CN¥15.56 Million | ▲ +398.4% |
| 1999 | -0.58x | CN¥-3.28 Million | CN¥5.67 Million | ▼ -103.1% |
| 1998 | 18.69x | CN¥72.67 Million | CN¥3.89 Million | — |